What Researchers Did
The researchers looked back at records of 109 patients with sudden hearing loss to compare those treated with hyperbaric oxygen therapy (HBOT) plus steroids against those treated with steroids only, and to see whether blood markers of inflammation were linked to recovery.
What They Found
In this retrospective study of 109 patients with sudden hearing loss, the group given HBOT plus steroids (59 sides) had a higher overall recovery rate than the steroid-only group (50 sides), particularly in severe cases. Blood markers of inflammation, the neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR), did not differ significantly by severity of hearing loss. In patients who also received HBOT, NLR and PLR were useful for predicting the effect. With cutoff values of 2.43 for NLR and 146.67 for PLR, lower values were linked to better recovery rates.
What This Means for Canadian Patients
For people with sudden hearing loss, this study found that those who received HBOT with steroids had higher recovery rates than those who received steroids alone, especially with severe hearing loss. The authors suggest that blood tests for NLR and PLR could be considered along with the severity of hearing loss when choosing treatment. Because patients were not randomly assigned, the study cannot show that HBOT caused the better recovery.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This was a retrospective comparison of 109 patients, not a randomized trial, so differences between the groups other than HBOT may have affected the recovery rates, and the abstract does not report the HBOT pressure or number of sessions.